Updates

South Africa Participating in Phase 3 Zoliflodacin Trial
19 Aug 2020

South Africa Participating in Phase 3 Zoliflodacin Trial

South Africa is one of four countries which is involved in a global phase 3 trial to assess the efficacy and safety of zoliflodacin, a new treatment for gonorrhoea, against standard treatments. Three sites across two provinces in South Africa are set to take part in the study.

Read more
We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.